2 reports

• The global liquid biopsy market should reach $4.5 billion by 2022 from $1.5 billion in 2017 at a compound annual growth rate (CAGR) of 24.2%, from 2017 to 2022. • The global noncancer market is expected to grow from $1.3 billion in 2017 to $2.6 billion in 2022 at a CAGR of 15.2% for the period 2017-2022. • The global cancer market...

This BCC Research report provides an in-depth study of the global biopsy devices methods by device, therapautic segments and geographic markets from 2012 through 2018, with five-year CAGR projections from 2015 through 2020. It focuses on key imaging technologies used in the process of performing biopsies such as ultrasound, magnetic resonance...